Author Correction: Increased diversity with reduced "diversity evenness" of tumor infiltrating T-cells for the successful cancer immunotherapy

Sci Rep. 2023 Apr 26;13(1):6816. doi: 10.1038/s41598-023-33836-2.

Akihiro Hosoi^{1

2}, Kazuyoshi Takeda^{3

4}, Koji Nagaoka^{1

2}, Tamaki Iino^{1

2}, Hirokazu Matsushita¹, Satoshi Ueha⁵, Shin Aoki⁵, Kouji Matsushima⁵, Masato Kubo^{6

7}, Teppei Morikawa⁸, Kazutaka Kitaura⁹, Ryuji Suzuki⁹, Kazuhiro Kakimi¹⁰

¹ Department of Immunotherapeutics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
² MEDINET Co. Ltd,, 2-3-12 Shin-Yokohama, Kohoku-ku, Yokohama, Kanagawa, 222-0033, Japan.
³ Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, 113-8421, Japan.
⁴ Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, 113-8421, Japan.
⁵ Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
⁶ Laboratory for Cytokine Regulation, Research Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, 230-0045, Japan.
⁷ Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Noda, Chiba, 278-0022, Japan.
⁸ Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
⁹ Repertoire Genesis Inc., Saito Bioincubator 104, 7-7-15 Saito-Asagi, Ibaraki-shi, Osaka, 567-0085, Japan.
¹⁰ Department of Immunotherapeutics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. kakimi@m.u-tokyo.ac.jp.

No abstract available

Publication types